CD163 and cholangiocarcinoma: Immunohistochemistry results from 38 patients also showed that the level of CD163+ macrophage in cholangiocarcinoma tissues was associated with a poor differentiation of tumor cells and tumor metastasis (Figure 2A, left and middle panels).